Ready4Action,True,2019-06-06 15:35:00,19.926,EXEL The teens will be gone for good I have stocked up
misskitty,True,2019-06-06 14:43:00,19.902,EXEL 1 Million Block Purchase
simbha,,2019-06-06 13:13:00,19.731,EXEL Market says we dont care what you say on conference calls Just bring some guidance to the revenues in your next earnings call Nada
misskitty,True,2019-06-06 12:17:00,19.776,EXEL
framus_morrigan,,2019-06-06 11:45:00,19.707,EXEL 1h chart Interesting level
jedi_delta,,2019-06-06 10:25:00,19.758,EXEL Analyst in audience asked mgmt if there were data available regarding CaboNivo COSMIC312 or CaboNivoIpiCOSMIC313 Senner referenced NCI Ph12 trail by Andrea Apolo This is the study referenced ascopubsorgdoiabs10120 and clinicaltrialsgovct2show So a third party is also running trails across a host of other GU onco indications Great segue to expand
jedi_delta,,2019-06-06 10:09:00,19.816,EXEL Senner CFO 14K patients in firstline RCC about 17K patients in secondline and later around 10K secondline patients and around 7K thirdline and later In HCC 14K diagnosed annually 30K deaths in HCC annually HCC market is evolving because of different liver diseases including NASH but HCC market will continue to grow based on whats happening in US
misskitty,True,2019-06-06 10:08:00,19.804,EXEL one big nasty short Benefiting from low volume I dont get it if you think management is greety check out Arrys
jedi_delta,,2019-06-06 10:03:00,19.798,EXEL Blair Conf QA Peters stated we think by design cabo can be effective across wide range of tumor types including COSMIC021 where we are looking those 20 different cohorts thats kind of how we view the execution of this pipeline and the product strategy
jedi_delta,,2019-06-06 09:49:00,20.09,EXEL WBlair Growth Stock Conference 2019 Familiar slide deck with updates EXEL Rxs in 100 clinical trails 50 for CABO singlet and IO combo Cabo is taking market share from Bayers Stivarga Regor in 2L HCC Vast majority of surveyed HCC Oncos intend to prescribe when aware of CELESTIAL trial data used in approval
